AEGiS-Reuters: Cellegy to stop HIV transmission study in Ghana

Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.

Cellegy to stop HIV transmission study in Ghana

Reuters NewMedia - November 8, 2005

NEW YORK - Cellegy Pharmaceuticals Inc. on Tuesday said it will stop a late-stage study of its vaginal gel on preventing HIV infection in Ghana because of a lower-than-expected rate of transmission of the virus.

Cellegy said the lower rate was possibly due in part to counseling on HIV prevention and the distribution of condoms.

The Huntingdon Valley, Pennsylvania, company said the effect of the gel, called Savvy, could not be determined in the trial, but it should continue to be studied for its effect in preventing the transmission of HIV.

051108
RE051105

Copyright © 2005 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .